PACIO Personal Functioning and Engagement Implementation Guide, published by HL7 International / Patient Care. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-pacio-pfe/ and changes regularly. See the Directory of published versions
Generated Narrative: AllergyIntolerance PFEIG-AllergyACE
clinicalStatus: Active
verificationStatus: Confirmed
category: Medication
criticality: High Risk
code: Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)
patient: Betsy Smith-Johnson Female, DoB Unknown ( http://example.org/identifiers/patient#10A3D58WH1600)
asserter: Betsy Smith-Johnson Female, DoB Unknown ( http://example.org/identifiers/patient#10A3D58WH1600)
lastOccurrence: 2011-10
Substance | Manifestation |
captopril 12.5 MG Oral Tablet | Hyperkalemia caused by angiotensin-converting enzyme inhibitor (disorder) |